Screener
Bone Biologics BBLG Q2 2026 earnings
Reported August 14, 2026 · Before market open
EPS-$0.43Miss by $0.04
EPS estimate-$0.39
Next report
Nov 13, 2026 (in 2 months)EPS estimate-$0.19
Versus estimates
Diluted EPS
FAQ
- When did Bone Biologics report Q2 2026 earnings?
- Bone Biologics (BBLG) reported Q2 2026 earnings on August 14, 2026 before market open.
- What were Bone Biologics's Q2 2026 revenue and EPS?
- Bone Biologics reported eps of $-0.43 for Q2 2026.
- Did Bone Biologics beat estimates in Q2 2026?
- EPS missed the consensus estimate of $-0.39 by $0.04.
- How did Bone Biologics's Q2 2026 results compare year-over-year?
- Compared to the same quarter a year prior, eps grew 67.7% from $-1.33.
- Where can I find Bone Biologics's Q2 2026 SEC filings?
- You can read the 10-Q periodic report (0001493152-26-038482) directly on SEC EDGAR. The filing index links above go to sec.gov.
